PetDx analyses demonstrate the potential of OncoK9 for detection of residual disease following excisional surgery and detection of cancer recurrence following therapy. SAN DIEGO, Jan. 16, 2023 /PRNewswire/ — PetDx® – The Liquid Biopsy Company for Pets™ has released a white paper…